ArticleKidney medicine2026

Incidence and Magnitude of Pseudo-decrease in Kidney Function With Oral Epidermal Growth Factor Inhibitor Osimertinib.

Maria Ilyas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.